Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Effects of hepatitis C virus core protein and nonstructural protein 4B on the Wnt/β-catenin pathway.

Jiang XH, Xie YT, Cai YP, Ren J, Ma T.

BMC Microbiol. 2017 May 25;17(1):124. doi: 10.1186/s12866-017-1032-4.

2.

Ubiquitin C-terminal hydrolase37 regulates Tcf7 DNA binding for the activation of Wnt signalling.

Han W, Lee H, Han JK.

Sci Rep. 2017 Feb 15;7:42590. doi: 10.1038/srep42590.

3.

A novel microRNA located in the TrkC gene regulates the Wnt signaling pathway and is differentially expressed in colorectal cancer specimens.

Dokanehiifard S, Yasari A, Najafi H, Jafarzadeh M, Nikkhah M, Mowla SJ, Soltani BM.

J Biol Chem. 2017 May 5;292(18):7566-7577. doi: 10.1074/jbc.M116.760710. Epub 2017 Jan 18.

PMID:
28100780
4.

Action and function of Wnt/β-catenin signaling in the progression from chronic hepatitis C to hepatocellular carcinoma.

Wang W, Pan Q, Fuhler GM, Smits R, Peppelenbosch MP.

J Gastroenterol. 2017 Apr;52(4):419-431. doi: 10.1007/s00535-016-1299-5. Epub 2016 Dec 29. Review. Erratum in: J Gastroenterol. 2017 Oct 11;:.

5.

Genetic alterations in hepatocellular carcinoma: An update.

Niu ZS, Niu XJ, Wang WH.

World J Gastroenterol. 2016 Nov 7;22(41):9069-9095. Review.

6.

Aberrant regulation of Wnt signaling in hepatocellular carcinoma.

Liu LJ, Xie SX, Chen YT, Xue JL, Zhang CJ, Zhu F.

World J Gastroenterol. 2016 Sep 7;22(33):7486-99. doi: 10.3748/wjg.v22.i33.7486. Review.

7.

A review on the diagnosis and treatment of hepatocellular carcinoma with a focus on the role of Wnts and the dickkopf family of Wnt inhibitors.

Shi J, Keller JM, Zhang J, Keller ET.

J Hepatocell Carcinoma. 2014 Mar 6;1:1-7. doi: 10.2147/JHC.S44537. eCollection 2014. Review.

8.

HBx mutations promote hepatoma cell migration through the Wnt/β-catenin signaling pathway.

Chen Z, Tang J, Cai X, Huang Y, Gao Q, Liang L, Tian L, Yang Y, Zheng Y, Hu Y, Tang N.

Cancer Sci. 2016 Oct;107(10):1380-1389. doi: 10.1111/cas.13014. Epub 2016 Sep 1.

9.

Chromatin remodeling gene ARID2 targets cyclin D1 and cyclin E1 to suppress hepatoma cell progression.

Duan Y, Tian L, Gao Q, Liang L, Zhang W, Yang Y, Zheng Y, Pan E, Li S, Tang N.

Oncotarget. 2016 Jul 19;7(29):45863-45875. doi: 10.18632/oncotarget.10244.

10.

A Genome-Wide RNA Interference Screen Identifies a Role for Wnt/β-Catenin Signaling during Rift Valley Fever Virus Infection.

Harmon B, Bird SW, Schudel BR, Hatch AV, Rasley A, Negrete OA.

J Virol. 2016 Jul 27;90(16):7084-97. doi: 10.1128/JVI.00543-16. Print 2016 Aug 15.

11.

How do persistent infections with hepatitis C virus cause liver cancer?

Mitchell JK, Lemon SM, McGivern DR.

Curr Opin Virol. 2015 Oct;14:101-8. doi: 10.1016/j.coviro.2015.09.003. Epub 2015 Sep 29. Review.

12.

Wnt3a: functions and implications in cancer.

He S, Lu Y, Liu X, Huang X, Keller ET, Qian CN, Zhang J.

Chin J Cancer. 2015 Sep 14;34(12):554-62. doi: 10.1186/s40880-015-0052-4. Review.

13.

DEAD-box protein p68 is regulated by β-catenin/transcription factor 4 to maintain a positive feedback loop in control of breast cancer progression.

Guturi KK, Sarkar M, Bhowmik A, Das N, Ghosh MK.

Breast Cancer Res. 2014 Dec 12;16(6):496. doi: 10.1186/s13058-014-0496-5.

14.

Dynamic interaction between astrocytes and infiltrating PBMCs in context of neuroAIDS.

Richards MH, Narasipura SD, Kim S, Seaton MS, Lutgen V, Al-Harthi L.

Glia. 2015 Mar;63(3):441-51. doi: 10.1002/glia.22763. Epub 2014 Oct 21.

15.

Wnt signaling in neuropsychiatric disorders: ties with adult hippocampal neurogenesis and behavior.

Hussaini SM, Choi CI, Cho CH, Kim HJ, Jun H, Jang MH.

Neurosci Biobehav Rev. 2014 Nov;47:369-83. doi: 10.1016/j.neubiorev.2014.09.005. Epub 2014 Sep 28. Review.

16.

Production and pathogenicity of hepatitis C virus core gene products.

Li HC, Ma HC, Yang CH, Lo SY.

World J Gastroenterol. 2014 Jun 21;20(23):7104-22. doi: 10.3748/wjg.v20.i23.7104. Review.

17.

GSK-3 as potential target for therapeutic intervention in cancer.

McCubrey JA, Steelman LS, Bertrand FE, Davis NM, Sokolosky M, Abrams SL, Montalto G, D'Assoro AB, Libra M, Nicoletti F, Maestro R, Basecke J, Rakus D, Gizak A, Demidenko ZN, Cocco L, Martelli AM, Cervello M.

Oncotarget. 2014 May 30;5(10):2881-911. Review.

18.

Identification of novel genes associated with renal tertiary lymphoid organ formation in aging mice.

Huang Y, Caputo CR, Noordmans GA, Yazdani S, Monteiro LH, van den Born J, van Goor H, Heeringa P, Korstanje R, Hillebrands JL.

PLoS One. 2014 Mar 17;9(3):e91850. doi: 10.1371/journal.pone.0091850. eCollection 2014.

19.

Niclosamide suppresses Hepatoma cell proliferation via the Wnt pathway.

Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Sueishi M, Yoshida T.

Onco Targets Ther. 2013 Nov 18;6:1685-93. doi: 10.2147/OTT.S50065. eCollection 2013.

20.

Mechanism of hepatitis C virus (HCV)-induced osteopontin and its role in epithelial to mesenchymal transition of hepatocytes.

Iqbal J, McRae S, Banaudha K, Mai T, Waris G.

J Biol Chem. 2013 Dec 27;288(52):36994-7009. doi: 10.1074/jbc.M113.492314. Epub 2013 Nov 15.

Supplemental Content

Support Center